Meet Neuland at CPHI India 2026 | Hall 2, Booth 2D38 | Yashobhoomi Convention Centre, New Delhi | 24-26 November 2026 Schedule a Meeting
Levetiracetam API (102767-28-2) used for Anticonvulsant — DMF Filed.
Small Molecule

Pharmacological Profile & Biological Activity
Levetiracetam acts by modulation of synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A in the brain.
Disclaimer: No information in this Catalog – including any reference to any product or service – constitutes an offer for sale or be constructed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, under Bolar Provision the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of patent scenario for their respective markets and will be responsible for all patent related liabilities.